Veru Inc (VERU)
1.26
+0.05
(+4.13%)
USD |
NASDAQ |
Apr 26, 16:00
1.26
0.00 (0.00%)
After-Hours: 20:00
Veru Research and Development Expense (Quarterly): 1.650M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.650M |
| September 30, 2023 | 6.668M |
| June 30, 2023 | 2.925M |
| March 31, 2023 | 22.86M |
| December 31, 2022 | 20.61M |
| September 30, 2022 | 27.16M |
| June 30, 2022 | 18.13M |
| March 31, 2022 | 15.54M |
| December 31, 2021 | 10.08M |
| September 30, 2021 | 8.256M |
| June 30, 2021 | 11.19M |
| March 31, 2021 | 7.573M |
| December 31, 2020 | 5.678M |
| September 30, 2020 | 3.268M |
| June 30, 2020 | 4.436M |
| March 31, 2020 | 3.930M |
| December 31, 2019 | 5.30M |
| September 30, 2019 | 3.605M |
| June 30, 2019 | 4.866M |
| March 31, 2019 | 2.911M |
| December 31, 2018 | 2.362M |
| September 30, 2018 | 3.028M |
| June 30, 2018 | 3.788M |
| March 31, 2018 | 2.077M |
| December 31, 2017 | 1.958M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.399M |
| June 30, 2017 | 0.3021M |
| March 31, 2017 | 1.208M |
| December 31, 2016 | 0.1711M |
| September 30, 2016 | 0.0033M |
| June 30, 2016 | 0.0227M |
| March 31, 2016 | 0.0351M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.650M
Minimum
Dec 2023
27.16M
Maximum
Sep 2022
9.67M
Average
6.668M
Median
Sep 2023
Research and Development Expense (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 17.95M |
| Regeneron Pharmaceuticals Inc | 1.177B |
| Bio-Path Holdings Inc | 2.276M |
| Aileron Therapeutics Inc | 1.972M |
| Scholar Rock Holding Corp | 34.96M |